Contact Us     Privacy Policy     Terms of Use                                                                                 © Copyright Pharma CI Conference & Exhibition 2008.  All Rights Reserved.
September 15-17, 2008
DAY 1 (Monday, September 15, 2008)
General Session
7:15 – 8:15
 Registration & Networking Breakfast in Exhibition Hall
Sponsored by: Gerson Lehrman Group
8:15 - 8:30
 Chairpersons’ Opening Remarks
Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Sue Ward
Director, Information and Knowledge Management
Pfizer
8:30 - 9:15
 Keynote Presentation: “New Realities for Drug/Device Development and Commercialization”
Wayne Rosenkrans
Distinguished Fellow, MIT Center for Biomedical Innovation
Chairman & President, Personalized Medicine Coalition
Chief Applications Officer, SciTech Strategies
9:15 - 10:00
 Keynote Presentation: "A Medical Device Perspective: Healthcare in the Digital Age".
Joseph DeVivo
Global President, Reconstructive Orthopaedics
Smith & Nephew
10:00 - 11:00
 Networking & Refreshments in Exhibition Hall
Sponsored by: The Mind Company
11:00 – 12:00
 “How Does This Change What We Do” Keynote Panel  
  MODERATOR:
Cliff Kalb
President
C. Kalb & Associates, LLC

PANELISTS:
Peter Burke
Senior VP & Chief Technology Officer
Steris Corp.

Tom Daulton
Vice President & General Manager
Cardinal Health

 Craig McHenry
Senior Director, Competitor Insights
Customer & Market Insights
Wyeth

Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Chandra Ramanathan    
Director, Global Business and Competitive
Intelligence  
Bristol-Myers Squibb

Sue Ward
Director, Information & Knowledge Management
Pfizer
  
12:00 – 12:30
 WalMart and You: From Diagnostics to Distribution Are You Doing Enough to Position Your Company
For 2010?
Steve Levy
Managing Director
Fletcher/CSI, LLC
12:30 – 1:30
 Networking Luncheon Keynote Presentation:   
Seeing Patterns That Produce Billion Dollar Insights: CI All-Stars Have Learned how to Turn Oceans ofData
Into Breakthrough Insights.  This presentation will share field research findings and case examples of how winning
CI organizations build systems that enable them to convert data into insights and intelligence that inform leadership
decision-making.
Chris Bogan
CEO
Best Practices
Interactive Roundtable Sessions:
Each session will be led by a facilitator who will facilitate the exchange of opinions, sharing of experiences and learning related to CI.  
Audience Participation.
  TRACK A
 TRACK B
 TRACK C
1:30 – 2:15
 Outsourcing CI
Bill Sammon        
Senior Director of Strategy
Information Analysis        
Pfizer
 Can "Weak Links" in the Value
Chain Inform Your Competitive
Strategy?
Craig McHenry
Senior Director, Competitor Insights
Customer & Market Insights
Wyeth
 Information Superiority Using
Mashup Technology Software
Richard Walker
Vice President
Denodo Technologies
2:15 – 3:00
 The Importance of the Medical
Science Liaison in CI
Neil H. Gray
Managing Partner
Healthcare Trends & Strategies, LLC
 Collecting, Analyzing and Reporting
Reliable Clinical Trial Data in
Emerging Markets
Dr. John Jakupciak
Director, Biomedical Research
Cipher Systems
 Competitive Intelligence at
Medical Conventions:
In-Sourcing
Eileen Kelly
Director, Business & Decision Analysis           
OSI Pharmaceutical
3:00 – 4:00
 Networking & Refreshments in Exhibition Hall
Sponsored by: Fletcher/CSI, LLC
Individual Presentations:
4:00 – 4:30
 BI/CI in Emerging Markets (Case
Study – BI/CI set-up of a Chinese
Pharma Company)
Holger Meissner
Co-Founder and President
Adler Life Sciences
 The Changing World of CI Inside
Pharma
Mark Little
Vice President, Business Intelligence &
Market Research
Covance
 The Case for Offshore
Information Analysis in a
Changing Industry - a Prudent
Strategy for Maximizing the
Return on CI
Rajesh Nair
CEO
Indegene
Panel Discussions:
4:30 – 5:30
 Is There a Balance Between
Strategic CI & Tactical CI?
Deborah Dauber
Associate Director, Competitive Intelligence        
Genentech

Jack Bush
Director, Global Marketing
Intelligence
Alcon Laboratories, Inc.

Monika Giese
Head Global CI
Novartis Pharma AG

J.J. Owen        
Associate Director, Scientific &     
Competitor Analysis
Millennium Pharmaceuticals
 Bring Competitive Intelligence to
the Top: Delivering Intelligence to
Executives
Gary McKnight        
Director, Information Services
ZymoGenetics, Inc.

Joshua Owolabi        
Assistant Director, Discovery &
Assessment Group        
TAP

Jeanne Penn        
Director, Business Information, LSD Business      
Genzyme

Carolyn J. Foster
Sr. Associate Director, Technology Assessment
Boehringer Ingelheim

Shefali Shah
Director of Market Analytics
Exelixis

David Stefanoni
Head of Business Intelligence
Sanofi-Aventis
 Challenges in Doing
Competitive Intelligence and
Market Research in the
Medical Device Industry
Included in that discussion will be
the difficulties in obtaining
pipeline information, having
limited access to medical device
product information, shorter
product development cycles
compared to Pharma (which
results in more competition
coming onboard faster)
Sam Rosenbaum
Manager, Market Research
Philips Medical Systems

David Van Mook
Manager, CI
Roche Diagnostics

5:30 – 8:30
Evening Socializing Events! Speed Dating for Business Development, Casino Gaming, Reception &
Networking.  Sponsored by Fletcher/CSI, LLC
DAY 2 (Tuesday, September 16, 2008)
7:15 – 8:15
 Registration & Networking Breakfast in Exhibition Hall
Sponsored by: Gerson Lehrman Group
8:15 - 8:30
 Chairpersons’ Opening Remarks
  TRACK A
 TRACK B
 TRACK C
8:30 – 9:15
 The Boehringer Ingelheim CTI
Internship Program
Indra Sethy-Coraci   
Principal Analyst   
Boehringer Ingelheim
 Pharma CI in Times of Economic
Uncertainty
Erik Glitman
Managing Director
Fletcher/CSI, LLC
 Delivering the Therapeutic:
Anatomy of a Drug – Device
Partnership
Case study of a medical device
manufacturer with a pharmaceutical
company to design, develop, and test
a delivery device for a novel
therapeutic delivered intra-cranially.
Arun Ranchod
Business Development Manager
MEDRAD Corporate Innovations
9:15 – 10:00
 From R&D to Patient – China’s
Evolving Pharmaceutical R&D
Sector & Realities Behind the
Great Wall
Sean D. Freston
Managing Director Asia/Pac
Proactive Worldwide
 Post-Small Molecule
Pharmaceuticals:  Patent Analysis
and CI  for
Combination Therapeutics
Avis Bridgers
Analyst
Nerac

Richard Hendriks, PhD
Analyst
Nerac
 Connecting Competitive
Intelligence, Customer
Needs, Technology
Innovation, and R&D
Investment using Technology
Roadmapping at Boston
Scientific.
This tool has been successful at
focusing Research and Development
investments at Boston Scientific
Technology roadmapping will be
explained as the mapping of the
elements of:
  • Competitive threats
  • Customer needs
  • Technology innovation
  • Research & development
    investments
Richard Traxler
Senior Manager of Technology Planning
Boston Scientific Corporation
10:00 – 11:00
 Networking & Refreshments in Exhibition Hall
Sponsored by: The Mind Company
12:30  – 1:30
 Networking Luncheon Keynote Presentation:
Discovery Without Borders – or Boundaries
From exploring Third World diseases to investigating emerging therapeutic trends, the search for relevant information today presents
new challenges – and opportunities.  This presentation will show how to unleash the power of a global network of information and
uncover original intelligence that’s often buried in secondary and tertiary sources – or even within your own enterprise.  
John Mahoney
Co-Founder and CTO
InfoNgen
General Session
1:30 - 2:15
 Tales From the Trenches - Client Communication Linked to CTI Success
Martha Matteo
2008 Board Member and Past President
Society of Competitive Intelligence Professionals (SCIP)
2:15 - 3:15
 Bringing Strategic Competitive Insights into New Product Planning & Business Development
  Moderator:
Chandra Ramanathan    
Director, Global Business and Competitive Intelligence  
Bristol-Myers Squibb
 Panelists:
Debbie Allison
Senior Director, Global Competitive Intelligence
Merck

Eileen Kelly        
Director, Business & Decision Analysis        
OSI Pharmaceuticals

Craig McHenry
Senior Director, Competitor Insights
Customer & Market Insights
Wyeth

Sam Rosenbaum
Manager, Market Research
Philips Medical Systems
3:15 - 3:45
 Networking & Refreshments in Exhibition Hall
Sponsored by: Fletcher/CSI, LLC
3:45 - 4:45
 Open Session: Bring your Day-to-Day Problems for us to Solve!  
  Monika Giese
Head Global CI
Novartis Pharma AG

Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Chandra Ramanathan    
Director, Global Business and Competitive Intelligence  
Bristol-Myers Squibb
 Sue Ward
Director, Information & Knowledge Management            
Pfizer

Friederike Wirtz-Brugger        
Associate Director, Scientific Competitive Intelligence (SCI)        
Sanofi-Aventis
4:45 - 5:00
 Summary & Attendee Q&A with the Chairpersons
Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Sue Ward
Director, Information & Knowledge Management            
Pfizer
5:00
 Conference Concludes
DAY 3 (Wednesday, September 17, 2008)
Post Conference Workshops (Separate Registration Required)
7:30 - 8:00
 Registration and Networking Breakfast
8:00 – 12:00
 The Wargame Workshop
Led by Deallus

This workshop is for CI professionals who want to learn more about when and why to run a Wargame as well as how to execute a
successful Wargame.  Wargame is a business tool used to improve decision making through role play and rigorous analysis of the
competitive landscape and your own organization’s capabilities and intentions.  Decisions are always made under uncertainty and
are therefore based upon assumptions.  The participants will leave with a deeper understanding what is required from a Wargame
to ensure your organization reap the most important benefits of a Wargame; identifying, challenging and improving its assumptions
about itself, the competitors, the market and the future.

  • Registration
  • Introduction to Wargaming
  • Designing a Wargame
  • Break
  • Analytical frameworks in Wargaming
  • Q&A
12:00 - 1:00    
 Networking Lunch
1:00 - 5:00
 A Workshop to Plan for Loss of Exclusivity Due to Patent Loss
Led by Lifescience Dynamics

  • Introductions & Objectives of the workshop
  • Objectives of delegates
  • The role of Lifecycle management and mature product team
  • Introduction to patent loss and generic invasion - Examples
  • Planning for patent loss driven by years to LOE
  • Patent loss defence strategies - full options review and target most promising - leave no stone unturned
  • Risk assessment
  • Intensity of barrier to implement
  • Required investment
  • Viability – Range of potential loss, range of potential returns
  • Most likely ROI
  • Task force team to drive the analysis and implement strategies and tactics
  • Q&A open forum
2008 Program Agenda:                                       
Woodbridge Hotel & Conference Center
Iselin, New Jersey
11:00 – 12:30
 (11:00-12:00)
Examining Generic Developments
in the US and EU
MODERATOR:
David Stefanoni
Head of Business Intelligence
Sanofi-aventis

PANELISTS:
Branimir Brankov
Sr. Director Global Competitive Intelligence
Merck

Jerry Hoffman        
Manager-Global Competitive
Intelligence Strategy        
Eli Lilly & Co.

Susanne Laningham        
Director Business Analysis &
Information        
Amgen

 (11:00-12:00)
Assessing Promotional Strategies
Thomas Han        
Senior Director, Strategic Marketing
Business Analysis
Biovail

Eileen Kelly        
Director, Business & Decision Analysis
OSI Pharmaceuticals

Millie Quinto Cason
VP, North American Operations
Deallus Inc.
 (11:00 - 11:45)
Competitive Aspects of Due
Diligence for International
M&A and Business Alliances
The presentation will provide an
overview of the international due
diligence process, focusing in
particular on the role of competitive
analysis. Issues discussed will
include the analysis of competitor
financials, evaluation of synergies,
market analysis, opportunity
assessment, and intellectual property
issues.
David Van Mook
Manager, CI
Roche Diagnostics
  (12:00-12:30)
International CI – Outsourcing
Primary Research in a Global Market
Chris Thompson
Managing Director
Navigate International
 (12:00-12:30)
Competitive Assessment of
Development, Manufacturing,
Regulatory, and (yes) Promotional
Strategies for Generic Small
Molecules and Biosimilars
Dave Hitchcoff
Vice President Consulting Services
Dunn Group
 (11:45 - 12:30)
Utilizing Business
Intelligence in Support of
M&A
Virtually all multi-billion dollar mergers
and acquisitions demand regulatory
approval; however, all successful
transactions regardless of size and
scope require a minimum level of
strategic analysis. We will discuss
how to design, implement and
generate essential business
intelligence processes and tools to
perform a world-class M&A
assessment. Tools such as product
portfolio analysis, internal networking,
financial analysis and more will infuse
process and discipline into
determining the strategic fit between
two business entities.
Jeffrey Beeny
Corporate Development – Business
Intelligence
Thermo Fisher Scientific